Topiramate Tablet, Film Coated
Product Images NDC 43063-998

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 43063-998). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063998 Label (43063998)

43063998 Label (43063998)
Label for Topiramate USP 25 mg oral film-coated tablets, containing 60 tablets per package. The label includes the NDC 43063-998-60 and is produced by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. The label displays dosage strength prominently and includes reorder number, lot number E20D71, and expiration date 05/2022.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of Topiramate, depicted as a hexose sugar analog with multiple oxygen-containing functional groups and sulfonamide moiety, consistent with its molecular configuration as shown.*
FDA Label Image

Figure-1jpg (Figure 1)

Figure-1jpg (Figure 1)
A Kaplan-Meier survival curve showing cumulative rates for time to first seizure over 500 days. The graph compares two dose groups of Topiramate: 50 mg/day (N=234) and 400 mg/day (N=236). The X-axis represents time in days, and the Y-axis shows cumulative rates. A p-value of 0.0002 is indicated on the chart.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate for placebo and Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day. The results are shown for two separate studies (Study 11 and Study 12), with error bars representing standard error. Statistical significance is indicated for higher doses of Topiramate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.